Skip to main content

BioRestorative Therapies, Inc.

BRTX
Exchange
Nasdaq
Industry
Services-Misc Health & Allied Services, NEC
SEC CIK
0001505497

No open-market purchases or sales by BioRestorative Therapies, Inc. insiders were filed in the last 90 days; 23 institutions reported holding it in 13F filings for Q2 2026, worth $1.00M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by BioRestorative Therapies, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for BioRestorative Therapies, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for BioRestorative Therapies, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Silva FranciscoVP of Research and Development171,384Oct 20, 20251
Alstodt LancePresident, CEO, COB187,497Oct 20, 20251
Rosa David ADirector–Feb 19, 20250
Williams Patrick F.Director–Feb 19, 20250
Kukekov Nickolay V.Director–Feb 19, 20250
Kristal Robert EugeneChief Financial Officer7,994Feb 19, 20250
Broadrick Dale10% Owner445,933Nov 5, 20240
Paccasassi RobertVP, QA and Reg Compliance–Feb 15, 20240

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 16, 2021 (view filing)Nov 16Same daySilva FranciscoVP of Research and DevelopmentPPurchase+7.83K$6.73+$52.7K+260,866.7%7.83K after2 lots
Nov 16, 2021 (view filing)Nov 16Same dayAlstodt LancePresident, CEO, COBPPurchase+4.50K$6.71+$30.2K+3.0%155.9K after4 lots
Nov 22, 2021 (view filing)Nov 193 daysSilva FranciscoVP of Research and DevelopmentPPurchase+4.00K$6.66+$26.6K+51.1%11.8K after
Nov 22, 2021 (view filing)Nov 22Same dayAlstodt LancePresident, CEO, COBPPurchase+396$6.31+$2.50K+0.3%156.3K after
Nov 23, 2021 (view filing)Nov 23Same dayAlstodt LancePresident, CEO, COBPPurchase+2.50K$6.00+$15.0K+1.6%158.8K after
Dec 2, 2021 (view filing)Dec 11 dayAlstodt LancePresident, CEO, COBPPurchase+799$5.50+$4.39K+0.5%159.6K after
Jan 5, 2022 (view filing)Jan 5Same dayAlstodt LancePresident, CEO, COBPPurchase+2.00K$3.85+$7.70K+1.3%161.6K after
Jan 24, 2022 (view filing)Jan 24Same dayAlstodt LancePresident, CEO, COBPPurchase+1.47K$3.40+$5.00K+0.9%163.1K after
Mar 29, 2022 (view filing)Mar 1-428 daysLateBroadrick Dale10% OwnerPPurchase+101.6K$5.54+$562.6K+50.9%301.3K after4 lots
Mar 29, 2022 (view filing)Mar 7-2122 daysLateBroadrick Dale10% OwnerPPurchase+54.4K$4.26+$231.6K+35.9%205.9K after4 lots
Apr 1, 2022 (view filing)Mar 29-313 daysLateBroadrick Dale10% OwnerPPurchase+15.7K$4.85+$76.1K+5.2%317.0K after3 lots
Apr 7, 2022 (view filing)Apr 52 daysBroadrick Dale10% OwnerPPurchase+46.0K$5.71+$262.6K+22.3%251.9K after2 lots
Apr 8, 2022 (view filing)Apr 62 daysBroadrick Dale10% OwnerPPurchase+2.50K$5.66+$14.2K+1.0%254.4K after
Apr 11, 2022 (view filing)Apr 83 daysKristal Robert EugeneChief Financial OfficerPPurchase+7.60K$5.71+$43.4KNew position7.60K after
May 2, 2022 (view filing)May 2Same dayAlstodt LancePresident, CEO, COBPPurchase+400$3.95+$1.58K+0.2%175.9K after2 lots
May 27, 2022 (view filing)May 261 dayAlstodt LancePresident, CEO, COBPPurchase+2.70K$3.52+$9.50K+1.5%178.6K after
May 31, 2022 (view filing)May 265 daysBroadrick Dale10% OwnerPPurchase+4.95K$3.51+$17.4K+1.9%259.3K after
May 31, 2022 (view filing)May 265 daysBroadrick Dale10% OwnerSSale−2.00K$3.44−$6.88K−0.8%257.3K after
Jun 1, 2022 (view filing)May 275 daysBroadrick Dale10% OwnerPPurchase+11.0K$3.61+$39.6K+4.3%268.3K after
Jun 3, 2022 (view filing)Jun 12 daysAlstodt LancePresident, CEO, COBPPurchase+200$4.60+$920+0.1%178.8K after
Jun 3, 2022 (view filing)Jun 12 daysBroadrick Dale10% OwnerPPurchase+9.21K$4.46+$41.1K+3.4%277.5K after
Jun 6, 2022 (view filing)Jun 24 daysBroadrick Dale10% OwnerPPurchase+1.00K$4.69+$4.69K+0.4%278.5K after
Jun 7, 2022 (view filing)Jun 7Same dayKristal Robert EugeneChief Financial OfficerPPurchase+200$4.56+$912+2.6%7.80K after
Jun 7, 2022 (view filing)Jun 3-64 daysBroadrick Dale10% OwnerPPurchase+4.20K$4.92+$20.7K+1.5%282.7K after2 lots
Jun 9, 2022 (view filing)Jun 81 dayAlstodt LancePresident, CEO, COBPPurchase+100$4.28+$428+0.1%178.9K after
Jun 9, 2022 (view filing)Jun 7-82 daysBroadrick Dale10% OwnerPPurchase+6.00K$4.56+$27.4K+2.1%288.7K after2 lots
Jun 13, 2022 (view filing)Jun 9-104 daysBroadrick Dale10% OwnerPPurchase+1.60K$4.26+$6.81K+0.6%290.3K after2 lots
Jun 14, 2022 (view filing)Jun 131 dayAlstodt LancePresident, CEO, COBPPurchase+200$3.95+$790+0.1%179.1K after2 lots
Jun 15, 2022 (view filing)Jun 141 dayAlstodt LancePresident, CEO, COBPPurchase+500$3.91+$1.96K+0.3%179.6K after
Jun 15, 2022 (view filing)Jun 132 daysBroadrick Dale10% OwnerPPurchase+1.30K$3.92+$5.10K+0.4%291.6K after
Jun 15, 2022 (view filing)Jun 15Same dayAlstodt LancePresident, CEO, COBPPurchase+700$3.68+$2.58K+0.4%180.3K after
Jun 15, 2022 (view filing)Jun 15Same dayKristal Robert EugeneChief Financial OfficerPPurchase+194$3.61+$700.34+2.5%7.99K after
Jun 17, 2022 (view filing)Jun 161 dayAlstodt LancePresident, CEO, COBPPurchase+600$3.73+$2.24K+0.3%180.9K after
Jun 17, 2022 (view filing)Jun 15-162 daysBroadrick Dale10% OwnerPPurchase+3.20K$3.78+$12.1K+1.1%294.8K after2 lots
Jun 23, 2022 (view filing)Jun 17-216 daysLateBroadrick Dale10% OwnerPPurchase+700$3.78+$2.65K+0.2%295.5K after2 lots
Jul 1, 2022 (view filing)Jun 301 dayAlstodt LancePresident, CEO, COBPPurchase+1.10K$3.10+$3.41K+0.6%182.0K after
Jul 5, 2022 (view filing)Jun 305 daysBroadrick Dale10% OwnerPPurchase+1.90K$3.08+$5.85K+0.6%297.4K after
Jul 13, 2022 (view filing)Jul 121 dayAlstodt LancePresident, CEO, COBPPurchase+700$2.95+$2.06K+0.4%182.7K after
Jul 15, 2022 (view filing)Jul 6-139 daysLateBroadrick Dale10% OwnerPPurchase+1.20K$3.01+$3.61K+0.4%298.6K after3 lots
Sep 9, 2022 (view filing)Aug 2614 daysLateSilva FranciscoVP of Research and DevelopmentSSale−3.96K$3.39−$13.4K−2.4%158.2K after
Sep 9, 2022 (view filing)Aug 26-2914 daysLateSilva FranciscoVP of Research and DevelopmentPPurchase+5.42K$3.28+$17.7K+3.4%163.6K after2 lots
Sep 9, 2022 (view filing)Aug 2911 daysLateSilva FranciscoVP of Research and DevelopmentPPurchase+307$3.32+$1.02K+2.6%12.1K after
Sep 23, 2022 (view filing)Sep 221 dayAlstodt LancePresident, CEO, COBPPurchase+200$2.92+$584+0.1%182.9K after2 lots
Sep 27, 2022 (view filing)Sep 234 daysBroadrick Dale10% OwnerPPurchase+300$2.83+$849+0.1%298.9K after
Oct 12, 2022 (view filing)Oct 111 daySilva FranciscoVP of Research and DevelopmentPPurchase+806$3.69+$2.97K+0.5%164.4K after
Oct 12, 2022 (view filing)Oct 12Same daySilva FranciscoVP of Research and DevelopmentPPurchase+725$3.39+$2.46K+0.4%165.1K after
Nov 21, 2022 (view filing)Nov 183 daysAlstodt LancePresident, CEO, COBPPurchase+1.00K$2.88+$2.88K+0.5%183.9K after
Nov 21, 2022 (view filing)Nov 21Same daySilva FranciscoVP of Research and DevelopmentPPurchase+943$2.62+$2.47K+0.6%166.0K after
Dec 7, 2022 (view filing)Dec 7Same dayAlstodt LancePresident, CEO, COBPPurchase+1.80K$2.99+$5.38K+1.0%185.7K after
Dec 28, 2022 (view filing)Dec 235 daysAlstodt LancePresident, CEO, COBPPurchase+300$3.01+$903+0.2%186.0K after2 lots